Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)
Phase 1
- Conditions
- Chronic Fatigue Syndrome
- Interventions
- Drug: IodoCarb (r)Other: Placebo
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- PharmaLundensis AB
- Target Recruit Count
- 40
- Registration Number
- NCT01793415
- Locations
- 🇸🇪
Probare i Lund AB, Lund, Sweden
Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal
Phase 2
Completed
- Conditions
- Chronic Obstructive Lung Disease
- Interventions
- Drug: Iodinated Active Charcoal (IodoCarb)
- First Posted Date
- 2011-07-27
- Last Posted Date
- 2013-11-15
- Lead Sponsor
- PharmaLundensis AB
- Target Recruit Count
- 40
- Registration Number
- NCT01404000
- Locations
- 🇸🇪
Dept of Respiratory Medcine & Allergology, Skane University Hospital, Lund, Sweden
News
No news found